Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert J Ossenkoppele

Showing results (21-30 of 193) with videos related to

Pageof 20
Sort By:
Cytometry. Part B, Clinical Cytometry|June 25, 2017
The interference of genetic associations in establishing the prognostic value of the immunophenotype in acute myeloid leukemiaThomas S van Solinge, Wendelien Zeijlemaker, Gert J Ossenkoppele, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2016
Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring SystemMargot F van Spronsen, Gert J Ossenkoppele, Theresia M Westers, et al.
Cancers|June 2, 2021
AML/Normal Progenitor Balance Instead of Total Tumor Load (MRD) Accounts for Prognostic Impact of Flowcytometric Residual Disease in AMLDiana Hanekamp, Jesse M Tettero, Gert J Ossenkoppele, et al.
The Journal of Pathology|April 15, 2003
ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a reviewRosita L ten Berge, Joost J Oudejans, Gert J Ossenkoppele, et al.
Frontiers in Oncology|February 12, 2021
MRD Tailored Therapy in AML: What We Have Learned So FarLok Lam Ngai, Angèle Kelder, Jeroen J W M Janssen, et al.
Cytometry. Part B, Clinical Cytometry|September 2, 2003
Novel multiparameter flow cytometry assay using Syto16 for the simultaneous detection of early apoptosis and apoptosis-corrected P-glycoprotein function in clinical samplesMarjolein A van der Pol, Henk J Broxterman, Guus Westra, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 17, 2005
Quantification of T-cell-mediated apoptosis in heterogeneous leukemia populations using four-color multiparameter flow cytometryTheresia M Westers, Ilse Houtenbos, Gerrit Jan Schuurhuis, et al.
Best Practice & Research. Clinical Haematology|February 10, 2015
Immunophenotyping for diagnosis and prognosis in MDS: ready for general application?Eline M P Cremers, Canan Alhan, Theresia M Westers, et al.
Hematological Oncology|May 23, 2006
Apoptosis resistance and response to chemotherapy in primary nodal diffuse large B-cell lymphomaJettie J F Muris, Chris J L M Meijer, Gert J Ossenkoppele, et al.
British Journal of Haematology|April 15, 2011
Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapyShikhar Aggarwal, Arjan A van de Loosdrecht, Canan Alhan, et al.
Pageof 20

Showing results (21-30 of 193) with videos related to

Sort By:
Pageof 20
Cytometry. Part B, Clinical Cytometry|June 25, 2017
The interference of genetic associations in establishing the prognostic value of the immunophenotype in acute myeloid leukemiaThomas S van Solinge, Wendelien Zeijlemaker, Gert J Ossenkoppele, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2016
Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring SystemMargot F van Spronsen, Gert J Ossenkoppele, Theresia M Westers, et al.
Cancers|June 2, 2021
AML/Normal Progenitor Balance Instead of Total Tumor Load (MRD) Accounts for Prognostic Impact of Flowcytometric Residual Disease in AMLDiana Hanekamp, Jesse M Tettero, Gert J Ossenkoppele, et al.
The Journal of Pathology|April 15, 2003
ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a reviewRosita L ten Berge, Joost J Oudejans, Gert J Ossenkoppele, et al.
Frontiers in Oncology|February 12, 2021
MRD Tailored Therapy in AML: What We Have Learned So FarLok Lam Ngai, Angèle Kelder, Jeroen J W M Janssen, et al.
Cytometry. Part B, Clinical Cytometry|September 2, 2003
Novel multiparameter flow cytometry assay using Syto16 for the simultaneous detection of early apoptosis and apoptosis-corrected P-glycoprotein function in clinical samplesMarjolein A van der Pol, Henk J Broxterman, Guus Westra, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 17, 2005
Quantification of T-cell-mediated apoptosis in heterogeneous leukemia populations using four-color multiparameter flow cytometryTheresia M Westers, Ilse Houtenbos, Gerrit Jan Schuurhuis, et al.
Best Practice & Research. Clinical Haematology|February 10, 2015
Immunophenotyping for diagnosis and prognosis in MDS: ready for general application?Eline M P Cremers, Canan Alhan, Theresia M Westers, et al.
Hematological Oncology|May 23, 2006
Apoptosis resistance and response to chemotherapy in primary nodal diffuse large B-cell lymphomaJettie J F Muris, Chris J L M Meijer, Gert J Ossenkoppele, et al.
British Journal of Haematology|April 15, 2011
Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapyShikhar Aggarwal, Arjan A van de Loosdrecht, Canan Alhan, et al.
Pageof 20